Israel to offer fourth dose of COVID-19 vaccine to people over 60
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Facing an alarming surge in coronavirus cases that threatens to overwhelm the nation’s hospital system, President Biden stepped up his administration’s pandemic response again on Tuesday and tried to reassure an anxious nation, telling Americans that “we should all be concerned about Omicron, but not panicked.”
In a White House address, Mr. Biden directed his defense secretary to get 1,000 military medical professionals ready to help where needed; he announced new vaccination and testing sites; and he said his administration was buying 500 million rapid Covid-19 tests to distribute free to the public beginning in January through a new website.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
...
Submitted by mike kraft on
As the world experiences new, more transmissible Covid-19 variants, scientists and health officials in the U.S. are still struggling to gather accurate and timely domestic data to help inform policy decisions to safeguard Americans.
Submitted by mike kraft on
(CBS) As COVID-19 infections continue to rise ahead of the holidays, experts are warning that there are tough days ahead in the fight against the virus — especially for those who are still unvaccinated.
The average number of new daily cases has nearly doubled since the beginning of November, with the U.S. now averaging 156,000 cases a day. On top of that, the fast-spreading Omicron variant has now been detected in all but five states.
Submitted by mike kraft on
Submitted by mike kraft on
A growing body of preliminary research suggests the Covid vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious Omicron variant.
All vaccines still seem to provide a significant degree of protection against serious illness from Omicron, which is the most crucial goal. But only the Pfizer and Moderna shots, when reinforced by a booster, appear to have initial success at stopping infections, and these vaccines are unavailable in most of the world.